Eleven Commonly Asked Questions About Ischemic Stroke

REFERENCES

• Roger VL, Go AS, Lloyd-Jones DM., et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association [erratum in: Circulation. 2012;125(22):el 002]. Circulation. 2012;125(1 ):e2–e220.
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994;308(6943):1540.
   Web of Science ®Google Scholar
• A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl I Med. 1991;325(18):1261–1266.
   PubMed Web of Science ®Google Scholar
• Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom Transient ischaemic Attack (UK-TIA) aspirin trial: final results. I Neurol Neurosurg Psychiatry. 1996;54(12): 1044–1054.
   Web of Science ®Google Scholar
• Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. I Neurol Neurosurg Psychiatry. 1996;60(2):197–199.
   PubMed Web of Science ®Google Scholar
• Taylor DW, Barnett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999;353(9171):2179–2184.
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Hemphill JC 3rd, Anderson C, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41 (9):2108–2129.
   PubMed Web of Science ®Google Scholar
• Goldstein JN, Marrero M, Masrur S, et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol. 2010;67(8):965.
   PubMed Web of Science ®Google Scholar
• Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. I Am Med Assoc. 1995;273(18):1421–1428.
   PubMed Web of Science ®Google Scholar
• Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet. 2004;363(9420):1491–1502.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: ACST trial. Stroke. 2004; 35(10):2425–2427.
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy-an evidence-based review. Neurology. 2005;65(6):794–801.
   PubMed Web of Science ®Google Scholar
• Halliday A, Harrison M, Hayter E., et al; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074–1084.
   PubMed Web of Science ®Google Scholar
• Furie KL, Kasner SE, Adams RJ., et al; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227–276.
   PubMed Web of Science ®Google Scholar
• Murad MH, Shahrour A, Shah N, Montori VM, Ricotta JJ. A systematic review and meta-analysis of randomized trials of carotid endarterectomy vs stenting. I Vasc Surg. 2011;53(3):792–797.
   Google Scholar
• Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid artery stenosis. N Eng I Med. 2010;363(1):11–23.
   PubMed Web of Science ®Google Scholar
• Yadav JS, Wholey MH, Kuntz RE., et al; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351 (15):1493–1501.
   PubMed Web of Science ®Google Scholar
• Coward LJ, McCabe DK Ederle J, Featherstone RL, Clifton A, Brown MM. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomized trial. Stroke. 2007;38(5):1526–1530.
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Derdeyn CP., et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.
   PubMed Web of Science ®Google Scholar
• International Carotid Stenting Study Investigators; Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985–997.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologist. Stroke. 2007;38(5):1655–1711.
   PubMed Web of Science ®Google Scholar
• Johnston SC, Rothwell PM, Nguyen-Hunyh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292.
   PubMed Web of Science ®Google Scholar
• Giles MF, Albers GW, Amarenco P, et al. Addition of brain infarction to the ABCD2 score (ABCD2I). Stroke. 2010;41 (9):1907–1913.
   PubMed Web of Science ®Google Scholar
• Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141 (2 suppl):e5765–e6005.
   Google Scholar
• Easton JD, Saver IL, Albers MJ, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276–2293.
   PubMed Web of Science ®Google Scholar
• You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e531S-e575S.
   Google Scholar
• Schwarz Ul, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl I Med. 2008;358(10): 999–1008.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Goldhaber SZ, Nelson K, et al. The Creating an OptimalWarfarin Nomogram (CROWN) study. Thromb Haemost. 2012;107(1 ):59–68.
   PubMed Web of Science ®Google Scholar
• Chong JY, Homma S, Mohr JP. Stroke as a complication of congenital heart disease. Curr Atherosclerosis Rep. 2005;7(4):263–267.
   PubMedGoogle Scholar
• Pristipino C, Anzola GP, Ballerini L, et al. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper [published ahead of print August 31, 2012]. Catheter Cardiovasc Interv. doi: 10.1002/ccd.24637.
   Google Scholar
• Kitsios GD, Lasker A, Singh J, Thaler DE. Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis. Neurology. 2012;78(13):993–997.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Ellenberg JFI, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;(4):382–390.
   Google Scholar
• Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke. 2002;33(3):706–711.
   PubMed Web of Science ®Google Scholar
• Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. I Am Coll Cardiol. 2006;47(2):440–445.
   PubMed Web of Science ®Google Scholar
• Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81 (5):602–608.
   PubMed Web of Science ®Google Scholar
• Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. I Am Coll Cardiol. 2007;49(7):797–802.
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20.
   Google Scholar
• Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PF0 in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105(22):2625–2631.
   PubMed Web of Science ®Google Scholar
• FurIan AJ, Reisman M, Massaro J., et al; CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–999.
   PubMed Web of Science ®Google Scholar
• Morales-Vidal S, Schneck MJ, Flaster M, Biller J. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease [review]. Expert Rev Neurother. 2012;12(2): 179–189; quiz 190.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation [erratum in: N Engl J Med. 2010;363(19):1877]. N Engl J Med. 2009;361(12):1139–1151.
   Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J., et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891.
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander IFI, McMurray JJ, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11): 981–992.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Eikelboom J, Joyner C., et al; AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl I Med. 2011;364(9):806–817.
   PubMed Web of Science ®Google Scholar
• Mandrola J. Apixaban (Eliquis) was supposed to beat dabigatran (Pradaxa) and rivaroxaban (Xarelto)...What gives? Online post on June 26, 2012. <http://blogs.theheart.org/trials-and-fibrillations-with-dr-john-mandrola/2012/6/26/new-post-26. > Accessed October 14,2012.
   Google Scholar
• Radecki RP. Dabigatran: uncharted waters and potential harms. Ann Intern Med. 2012;157(1):66–68.
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. I Am Coll Cardiol. 2011;57(11): el 01—e198.
   Google Scholar
• 2012 focused update of the ESC Guidelines for the Management of Atrial Fibrillation: an update of the 2010 ESC Guidelines for the Management of Atrial Fibrillation. Developed with the special contribution of the European Heart Rhythm Association [published online ahead of print August 24,2012]. Eur Heart J.
   Google Scholar
• Cervical Artery Dissection in Stroke Study Trial Investigators. Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS). Int J Stroke. 2007;2(4):292–296.
   PubMed Web of Science ®Google Scholar